Logout

Follow Us

GSK

CEF Lead Executives

Latest Sustainability Reporting

Highlights



  • Reduced Scope 1 and 2 emissions by an additional 12% in 2024, bringing total reductions to 36% since 2020.
  • Met or exceeded 91% of its Responsible Business Performance Rating metrics in 2024.
  • 66% of operational sites are now under biodiversity management plans. 
  • Reduced overall water use by 28% (2020 baseline).
  • Scored 2nd in the Access to Medicines Index 2024 among 20 of the world’s largest pharmaceutical companies.
  • Received an A from CDP for both climate change and water security, and a B for forests.
  • Pledged £45 million ($57 million) and its expertise to a new global network to find, test, and scale solutions to anti-microbial resistance.
  • Women held 48% of VP-and-above roles globally and ethnically diverse leaders held 38.3% of VP-and-above roles in the U.S. at the end of 2024, surpassing company targets of 45% and 30% respectively.

Recent News

2025

Said in its annual report that it will make changes relating to its inclusion and diversity initiatives, including no longer setting diversity targets for its leadership and supplier programs. GSK noted that “it remained committed to operating as a responsible business with an inclusive culture,” according to reporting from Reuters. (March 2025)

REUTERS »

2024

GSK / IGNIS GSK, in partnership with Schneider Electric, announced a Virtual Power Purchase Agreement (VPPA) with renewable energy group IGNIS. This VPPA will facilitate the supply of 200 GWh of renewable electricity certificates per year. This VPPA will account for approximately 50% of GSK’s total electricity demand in Europe for 12 years, starting in mid-2026. Schneider Electric advised during the project evaluation and PPA negotiation phases. (March 2024)

PR »

2023

 Will start Phase III trials of a low emissions version of its metered dose inhaler, using a next generation propellant, in 2024. This could reduce GHG emissions from inhaler use by approximately 90%. (The current propellant accounts for 49% of GSK’s carbon footprint.) (Dec 2023)

PR »


Joined the CEF member network August 2023!


2022

GSK launched a Sustainable Procurement program that will require and support suppliers to take action on carbon, power, heat, transport, water, waste, and sustainable deforestation-free sourcing of materials. Specific areas of action include disclosing emissions; setting carbon reduction targets; switching to renewable energy; achieving water neutrality in water stressed areas; waste reductions of 10%; aligning to the company’s responsible sourcing minimum standards; and, for transport suppliers, providing green transport solutions. (Sept 2022)

MORE »


The Carbon Call — Twenty corporate, scientific, philanthropic, and intergovernmental organizations, hosted by the ClimateWorks Foundation, launched a new collaboration to accelerate the development of reliable and interoperable carbon accounting, with a focus on carbon removal and methane, indirect, and land-sector emissions. Participating organizations will work to advance universal accounting methodology standards, expand access to reliable GHG emissions and removal data, and strengthen the interoperability of digital accounting infrastructure. Corporate signatories (including CEF member Microsoft plus Capricorn Investment Group, EY, GSK, KPMG, and Wipro) commit to annually and transparently reporting on their GHG emissions and offsets, including all scopes and classes. (Feb 2022)

MORE »

2021

Lowering Emissions by Accelerating Forest finance (LEAF) Coalition — A public-private initiative to mobilize more than $1 billion to protect tropical forests from deforestation, protect the rights of local Indigenous Peoples, and support sustainable development in emerging economies. Coordinated by nonprofit Emergent, it involves the U.S., the U.K, Norway, and corporate partners Amazon, Airbnb, Bayer, Boston Consulting Group, GSK, McKinsey, Nestlé Salesforce, and Unilever. (April 2021)

MORE »

Share by: